AIM Competitors & Alternatives
Compare AIM ImmunoTech Inc. with similar stocks in the same industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
AIM
Main Stock$1.15
Tradestie Score
49
Market Cap
$7.26M
Revenue Growth
-0.3%
Analyst Upside
+1116.2%
Top Competitors
170 stocks in BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AMGN
Amgen Inc
|
$338.59
|
$160.70B | 26.7 | 68 | Compare |
|
GILD
Gilead Sciences Inc
|
$143.28
|
$137.92B | 22.1 | 66 | Compare |
|
ARGX
argenx SE American Depositary Shares
|
$851.72
|
$46.96B | 35.7 | 58 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$108.25
|
$24.57B | - | 50 | Compare |
|
BIIB
Biogen Inc. Common Stock
|
$176.76
|
$22.61B | 16.3 | 57 | Compare |
|
NBIX
Neurocrine Biosciences Inc
|
$138.98
|
$13.59B | 32.9 | 65 | Compare |
|
EXEL
Exelixis Inc
|
$42.59
|
$11.09B | 18.0 | 57 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$42.20
|
$10.74B | - | 58 | Compare |
|
QGEN
QIAGEN N.V.
|
$51.89
|
$10.04B | 26.8 | 59 | Compare |
|
TECH
Bio-Techne Corp.
|
$64.63
|
$9.33B | 133.2 | 55 | Compare |
More AIM Analysis
Data updated: Feb 03, 2026 | Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) (SIC 2836)
170 stocks in this industry